← Open Payments lookup

RICHARD KOTOMORI: Open Payments

NPI 1215059084 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,397 in 181 payments from 22 companies in 2025. Trend: 2023 $2,984 · 2024 $2,531 · 2025 $3,397

Food & beverage: $3,397
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.28$596
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$312
Alkermes, Inc.18$310
Vanda Pharmaceuticals Inc.17$289
Collegium Pharmaceutical, Inc.17$239
E.R. Squibb & Sons, L.L.C.16$227
ABBVIE INC.9$203
Otsuka America Pharmaceutical, Inc.9$180
Tris Pharma Inc10$167
Axsome Therapeutics, Inc.7$156

Products named: INGREZZA, CAPLYTA, ARISTADA, Jornay PM, COBENFY, REXULTI, VRAYLAR, HETLIOZ.

Industry payments across CA — which companies pay providers there.